Stay updated on Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial page.

Latest updates to the Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision label in the page footer was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.4.2 was added, replacing the previous v3.4.1 label on the history page.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no substantive changes to study content or page layout are visible.SummaryDifference0.0%

- Check47 days agoChange DetectedGlossary toggle is now shown, and changes are indicated with green for additions and red for deletions. The revision tag updated to v3.4.0 and capitalization of No FEAR Act data was standardized.SummaryDifference0.4%

- Check62 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added, and the 'HHS Vulnerability Disclosure' link and the older 'Revision: v3.3.2' entry were removed.SummaryDifference0.1%

Stay in the know with updates to Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial page.